UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2217) 2217
science & technology (2125) 2125
carbazoles - therapeutic use (2088) 2088
life sciences & biomedicine (2037) 2037
male (1470) 1470
propanolamines - therapeutic use (1428) 1428
female (1226) 1226
adrenergic beta-antagonists - therapeutic use (1099) 1099
animals (1015) 1015
carbazoles - pharmacology (935) 935
middle aged (874) 874
carvedilol (752) 752
heart failure - drug therapy (671) 671
cardiovascular system & cardiology (619) 619
aged (603) 603
adult (561) 561
cardiac & cardiovascular systems (558) 558
pharmacology & pharmacy (558) 558
treatment outcome (548) 548
carbazoles - administration & dosage (465) 465
heart failure (416) 416
propanolamines - pharmacology (355) 355
abridged index medicus (354) 354
carbazoles - adverse effects (336) 336
rats (325) 325
metoprolol - therapeutic use (307) 307
dose-response relationship, drug (284) 284
propanolamines - administration & dosage (282) 282
double-blind method (271) 271
mice (265) 265
blood pressure - drug effects (252) 252
hypertension - drug therapy (251) 251
adrenergic beta-antagonists - pharmacology (248) 248
drug therapy (248) 248
heart failure - physiopathology (247) 247
antihypertensive agents - therapeutic use (233) 233
heart rate - drug effects (227) 227
time factors (224) 224
oncology (223) 223
propanolamines - adverse effects (219) 219
carbazoles - chemistry (204) 204
analysis (200) 200
adrenergic beta-antagonists - administration & dosage (188) 188
vasodilator agents - therapeutic use (185) 185
adrenergic beta-antagonists - adverse effects (179) 179
carbazoles - pharmacokinetics (177) 177
heart failure - mortality (176) 176
prospective studies (176) 176
care and treatment (174) 174
drug therapy, combination (173) 173
randomized controlled trials as topic (173) 173
neurosciences & neurology (168) 168
medicine & public health (161) 161
chronic disease (155) 155
follow-up studies (153) 153
research (151) 151
hypertension (145) 145
aged, 80 and over (143) 143
clinical trials as topic (141) 141
general & internal medicine (139) 139
rats, sprague-dawley (139) 139
neurosciences (138) 138
hemodynamics - drug effects (133) 133
ventricular function, left - drug effects (132) 132
carbazoles (131) 131
disease models, animal (131) 131
veterinary sciences (130) 130
piperidines - therapeutic use (128) 128
cell line, tumor (126) 126
medicine, general & internal (126) 126
antineoplastic agents - therapeutic use (123) 123
lung neoplasms - drug therapy (123) 123
anti-inflammatory agents, non-steroidal - therapeutic use (122) 122
cardiology (121) 121
stroke volume - drug effects (120) 120
angiotensin-converting enzyme inhibitors - therapeutic use (119) 119
cancer (116) 116
apoptosis (115) 115
dogs (115) 115
health aspects (115) 115
beta blockers (113) 113
biochemistry & molecular biology (113) 113
cardiomyopathy, dilated - drug therapy (112) 112
enzyme inhibitors - pharmacology (112) 112
bisoprolol - therapeutic use (110) 110
risk factors (110) 110
carcinoma, non-small-cell lung - drug therapy (109) 109
protein kinase inhibitors - therapeutic use (108) 108
research article (107) 107
adolescent (106) 106
hypertension - physiopathology (105) 105
proteins (104) 104
echocardiography (102) 102
peripheral vascular disease (102) 102
propanolamines - pharmacokinetics (100) 100
administration, oral (99) 99
indoles - pharmacology (99) 99
cell biology (97) 97
pharmacology/toxicology (97) 97
ventricular dysfunction, left - drug therapy (97) 97
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2896) 2896
German (58) 58
Russian (55) 55
Japanese (44) 44
Chinese (21) 21
French (21) 21
Italian (19) 19
Portuguese (16) 16
Spanish (15) 15
Hungarian (6) 6
Czech (4) 4
Danish (4) 4
Turkish (4) 4
Polish (3) 3
Ukrainian (3) 3
Dutch (2) 2
Swedish (2) 2
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 08/2017, Volume 377, Issue 9, pp. 829 - 838
Alectinib, a potent ALK tyrosine kinase inhibitor, was more effective and somewhat less toxic than crizotinib when used as primary therapy in patients with ALK... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Central Nervous System Neoplasms - secondary | Young Adult | Pyridines - adverse effects | Anaplastic Lymphoma Kinase | Antineoplastic Agents - adverse effects | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Receptor Protein-Tyrosine Kinases - analysis | Pyrazoles - adverse effects | Pyridines - therapeutic use | Crizotinib | Carbazoles - adverse effects | Kaplan-Meier Estimate | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Animals | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Piperidines - adverse effects | Intention to Treat Analysis | Carbazoles - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Central Nervous System Neoplasms - drug therapy | Drugs | Care and treatment | Analysis | Comparative analysis | Lung cancer, Non-small cell | Health aspects | Systemic diseases | Toxicity | Lung cancer | Central nervous system | Non-small cell lung carcinoma | Oncology | Nervous system | Metastasis | Radiation therapy | Patients | Lymphoma | Cancer therapies | Survival | Mutation | Protein-tyrosine kinase | Drug dosages | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 01/2016, Volume 34, Issue 2, pp. 123 - 129
Journal Article
The Lancet (British edition), ISSN 0140-6736, 07/2017, Volume 390, Issue 10089, pp. 29 - 39
Summary Background Alectinib, a potent, highly selective, CNS-active inhibitor of anaplastic lymphoma kinase (ALK), showed promising efficacy and tolerability... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Single-Blind Method | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Piperidines - blood | Brain Neoplasms - secondary | Pyridines - adverse effects | Carcinoma, Non-Small-Cell Lung - secondary | Neoplasm Grading | Antineoplastic Agents - adverse effects | Pyrazoles - blood | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Carbazoles - blood | Pyrazoles - adverse effects | Pyridines - therapeutic use | Carcinoma, Non-Small-Cell Lung - pathology | Carbazoles - adverse effects | Lung Neoplasms - enzymology | Kaplan-Meier Estimate | Receptor Protein-Tyrosine Kinases - metabolism | Protein Kinase Inhibitors - blood | Pyridines - blood | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Piperidines - adverse effects | Antineoplastic Agents - blood | Aged | Carbazoles - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Medical colleges | Respiratory agents | Care and treatment | Lymphomas | Lung cancer, Non-small cell | Product development | Pharmaceutical industry | Analysis | Toxicity | Funding | Lung cancer | Central nervous system | Metastasis | Kinases | Evidence-based medicine | Recruitment | Motivation | Audio frequencies | Safety | Toxic diseases | Drug dosages | Protein-tyrosine kinase | Effectiveness | Cut-off | Data processing | Group dynamics | Patients | Survival | Lymphoma | Chemotherapy | Inhibitors | Interactive systems | Death | Mutation | Cancer | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 03/2016, Volume 34, Issue 7, pp. 661 - 668
Journal Article
Toxicology and applied pharmacology, ISSN 0041-008X, 12/2013, Volume 273, Issue 3, pp. 442 - 455
Although reactive oxygen species (ROS) such as superoxide, hydrogen peroxide and hydroxyl radical are generated as the natural byproduct of normal oxygen... 
Oxidative stress | Toxicology | Pharmacology | Disease | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Diabetes Mellitus - pathology | Vascular Diseases - prevention & control | Benzopyrans - therapeutic use | Reactive Oxygen Species - metabolism | Vascular Diseases - pathology | Stilbenes - therapeutic use | Humans | Oxidative Stress - physiology | Neurodegenerative Diseases - prevention & control | Neoplasms - prevention & control | Propanolamines - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Inflammatory Bowel Diseases - pathology | Disease Models, Animal | Nebivolol | Inflammatory Bowel Diseases - prevention & control | Neurodegenerative Diseases - pathology | Osteoporosis - prevention & control | Hydrogen Peroxide - metabolism | Antioxidants - therapeutic use | Diabetes Mellitus - prevention & control | Animals | Osteoporosis - pathology | Ethanolamines - therapeutic use | Carbazoles - therapeutic use | Oxidative Stress - drug effects | Neoplasms - pathology | Angiotensin Receptor Antagonists - therapeutic use | Antioxidants | Chemotherapy | Hydrogen peroxide | Enzyme inhibitors | Resveratrol | Polyols | Cancer | Index Medicus | OXIDATION | APOPTOSIS | ANTIOXIDANTS | ENZYME INHIBITORS | MITOCHONDRIA | CELL PROLIFERATION | 60 APPLIED LIFE SCIENCES | ANGIOTENSIN | STRESSES | OXYGEN | HYDROXYL RADICALS | CARCINOGENESIS | DISEASES | NECROSIS | METABOLISM | HYDROGEN PEROXIDE | INFLAMMATION
Journal Article